thẽ smokeout
To mark the 10th anniversary of the Great American Smokeout, the American Cancer Society has launched a nationwide Star Quest -not for those who sins, juggle or tap dance, but for people who have quit smoking over the past decade.
The search is on to identify these brave quitters and honor them during the country-wide celebrations on Smokeout Day, November 20. Traditionally on this remarkable day, smokers try to kick the habit for at least 24 hours. During past Smokeouts, millions of smokers have accepted this challenge, tossing away cigarette packs for a day, a month, or for good.
Star Quest isjust one of the many activities of the day. Local American Cancer Society Units will search out and focus the spotlight on stars in their communities: the worker who no longer needs a drag to make it through the day; the mother of two who thought she needed cigarettes to "calm her nerves," -but found she didn't; the teenager who no longer feels pressured to smoke by peers, and all the others.
"I'm a star" buttons will be available. The ex-smoking stars -and smokers who want to join them -should contact local ACS Units for details on Smokeout happenings in their communities.
The Adopt-a-Smoker program, so successful in past Smokeouts, will continue thisyear. Adoption papers spell out an agreement wherein a non-smoker will provide extra encouragement, understanding, and perhaps some "munchies" to a smoking friend who is quitting for the day.
The indomitable Larry Hagman will lead the Smokeout for the sixth time. He will make a new television spot urging smokers to "make this the year to blow smoking out of their lives."
Thousands of ACS volunteers join Hagman in promising help to those trying to quit. Setting up displays in shopping malls, public plazas, and other downtown areas, they will offer stickers, buttons, tips on quitting, and pats on the back.
Companies, colleges, schools, and Reasons to quit are many. Representing less than one third of the American adult population, smokers account for about 83% of all lung cancercases. Lung cancer has recently surpassed breast cancer as the leading cancer killer of women; it has long been the number one cause of cancer death in men. Cigarette smoking is a significant factor in other cancers, aswell: cancers of the mouth, esophagus, larynx, pharynx, bladder, kidney, and pancreas. It has also been implicated in cervical cancer.
A recent ACS study of the effectsof cigarette smoke on non-smokers found an increased risk of lung cancer among non-smoking wives whose husbands smoke. An estimated 350,000 Americans will die prematurely this year of diseases linked to smoking -as many Americans ashave been killed in all the wars fought in this century.
Last year a record-breaking four out of every 10 smokers, an estimated 23 million people, partic;ipated in the'Great American Smokeout. Of the participants, about 7 million were able to make it through the day without lighting up; 3.7 million were still not smoking four to five days after the Smokeout.
TOBACCO PRODUCTS LITIGATION PROJECT
The American Public Health Association (APHA) has joined with the Massachusetts based Tobacco Products litigation Project (TPLP) in support of legal action against the tobacco industry. The two organizations filed amicus briefs urging federal courts to permit cases to proceed which allege that tobacco companies have inadequately wamed the public of the serious health risks of smoking. APHA President, William H. Foege, MD, stated, "Holding tobacco companies responsible for the adverse effects of their products seems as logical as having pharmaceutical companies be responsible for any adverse effects from vaccines and drug products." Dr. Foege noted, "Tobacco is the smallpox pestilence of the 1980s. It is another tyranny we don't need." On April 7, in Philadelphia, a threejudge panel of the Court of Appeals for the Third Circuit in the case of Cipollone v Liggett Group. Inc. ruled that Congress intended the cigarette package wamings -which first appeared in 1966 -to protect the manufacturers from lawsuits claiming they should have given stronger warnings; and further, they should simply have refrained from deliberate efforts to confuse the public about the relation between smoking and disease.
On April 17, 1986 APHA filed two amicus briefs: the first was in support of plaintiff Cipollone's petition for rehearing of the case. Unfortunately, that petition was denied by the Third Circuit Court. In that same brief, APHA filed a request to the Third Circuit Court of Appeals, that all judges on that court reconsider the propriety of the panel's ruling. The second brief was in opposition to the Liggett Group, Inc.'s motion to dismiss a subsequent case, Palmer v Liggett Grout;
Inc. on the basis of the Cipollone ruling; this case is set for trial in Massachusetts Federal District Court.
Among the arguments presented by APHA and TPLP are: • The act (The Federal Cigarette Labeling and Advertising Act of 1965) does not prohibit cigarette manufacturers from giving consumers more detailed or effective warnings. It is evident that cigarette companies themselves do not feel pre-empted by the Act, since they regularly attempt to reach the public through paid advertisements with their own views on "smoking and health." • When Congress passed the Act, it contemplated that products liability cases alleging cigarette manufacturers' failure to warn would continue; and • Even today, when squarely confronted with the issue in the case of labeling smokeless tobacco prod-448 ucts, Congress believed it could achieve national uniformity in tobacco products labeling regulation without preempting tobacco products liability claims involving failure to warn. The TPLP is an autonomous project of the Clean Indoor Air Educational Foundation, a nonprofit corporation dedicated to protecting the public from the dangers of tobacco smoke through public information and legal action.
At the APHA Annual Meeting last year in Washington, DC, APHA President Feege announced that APHA would activate an Anti-Tobacco Initiative aimed at stopping the promotion of tobacco products worldwide. APHA will be actively involved with anti-tobacco efforts to restrict tobacco advertising, develop local smoking restriction ordinances, discourage tobacco product availability to youth, establish smoke-free health facilities, and to promote other anti-tobacco activities.
APHA hopes that other health organizations will follow its lead and support similar cases against the tobacco industry.
TAKING CONTROL OF CANCER
"Everything causes cancer!" "I Jove having a suntan. There's no waysomething ashealthyasthe sun can give you cancer!" "I've been a smoker for 15years.
It's too late for me to do anything to avoid lung cancer"
These statements about cancer have two things in common: first, they reflect an attitude of helplessness regarding cancer prevention, and second, they all are incorrect. Unfortunately, though, this sense of inevitability is common, despite the many advances in the fight against cancer.
To dispel this mistaken sense of hopelessness, the American Cancer Society announces a new public education program, "Taking Control," which offers ten simple steps people can take now to reduce their risk of getting cancer, and possibly prevent the disease.
"Taking Control" is one of our most significant programs to date because it represents the Society's new emphasis on cancer prevention," said Charles A. LeMaistre, MD, the incoming president of the Society "Most scientists now believe that our daily habits -what we eat and drink, whether we smoke, and how often we expose ourselves to the sun determine to a great extent our risk of getting many cancers," he said. 'All of these factors can be controlled easily We have the power to lessen our chances of getting this disease." "Taking Control" is the first ACS program to integrate all aspects of cancer prevention -diet, exercise, and general health habits -into a program that can be adapted practically to one's lifestyle. It offers ten steps -five habits to adopt and five to curtail -that have been proven through epidemiological studies and laboratory experiments to playa role in curtailing the development of certain cancers. The five "protective factors" are practices that should be adopted; the "risk factors" are habits that should be curtailed or abandoned.
"We know that a third of all cancer is linked to cigarette smoking. And other cancers, particularly breast, prostate, and colon, are related to diet," said Dr.
LeMaistre. "By cutting out smoking and eating more of the foods that may inhibit cancer, you can do a lot to reduce your risk." "Taking Control" offers ten steps to reduce cancer risk.
The program will be offered by the Society's 3,242 local Units with special emphasis on workplace seminars, houses of worship, and supermarkets. About 250,000 public education volunteers have been mobilized, allover the country, for this massive effort. In addition to the printed material, videotape and slide presentations have been developed. A film using science fiction themes and special effects also has been produced.
"The material we've put together for this program has one purpose" -to motivate people to adopt these practices," said John R. Seffrin, PhD, chairman of the Society's National Public Education Committee.
"We've been very successful in increasing the cure rate for patients who already have cancer," Dr. LeMaistre said. "Now we have the knowledge that will enable us to attack cancer before it starts. This is some of the best news about cancer we can offer the public. There's no magic potion to ward off cancer, but we are far from helpless."
NURSES AND CIGARETTES
Despite increasing numbers of lung cancer patients and irrefutable evidence AAOHN JOURNAL of the disease's link to tobacco use, large numbers of nurses are taking up cigarette smoking -and The University of Texas at Austin School of Nursing is trying to do something about it.
According to research done by Dr. Craig Stotts at the UTAustin School of Nursing, fewer nurses are giving up smoking than have members of other groups despite active campaigns to discourage nurses from smoking.
A registered nurse with a doctorate in public health, Dr. Stotts, who teaches four courses in community health nursing in the School of Nursing, studied reports from several states as well as national statistics to discover why the number of nurses smoking is not shrinking as are smokers in other health professions.
In 1975, 39% of the nurses in the U.s. smoked. By 1983, the number was 25%. On the other hand, physicians who smoked made up 40% of their group in 1973, but that group shrank to 14% by 1983.
Nurses have a higher rate of smoking than the American public as a whole and most of them take up smoking during their nurses' training, Dr. Stotts found. He hopes his research will define what is being done and not being done that may help reduce the number of nurses who smoke cigarettes.
"Nurses who continue to smoke do not perceive themselves as role models," Dr. Stotts said. "They see themselves as powerless and they suffer from poor self-esteem."
Reasons nurses give for not giving up smoking are stress, professional, frustration and lack of willpower.
UTAustin's School of Nursing has plans for a smoking prevention campaign that will focus on student nurses and feature workshops on coping with stress, socialization into the professional role of health exemplar (health-professional role model) and a public relations campaign to improve the image of nursing as a profession.
Asked about the importance of the campaign, Dr. Stotts said the public looks to nurses as experts in health and that a nurse smoking a cigarette does not project that image.
"If we had not had cigarettes, lung cancer would be one of the rarest diseases around," he said.
STATEMENT FROM NATIONAL CANCER INSTITUTE
"In cancers that are curable like the SEPTEMBER 1986; VOL. 34, NO. 9 lymphomas, dose intensity of chemotherapy is extremely important. If you reduce drug doses, you lose lives as a result," Vincent T. DeVita, director of the National Cancer Institute (NCI), said at the Annual Meeting of the American Association for Cancer Research held in Los Angeles in May In delivering the Tenth Richard and Hinda Rosenthal Foundation Award Lecture, "Chemotherapy of the Lymphomas: Looking Back -Moving Forward," Dr. DeVita presented data from (human) clinical trials in lymphomas showing that reduction in chemotherapy leads to reduction in cure rate. These data are consistent with data from animal studies.
He reviewed 20-year follow-ups of patients with two types of adult lymphomas that are curable with chemotherapy: Hodgkin's disease and diffuse large-cell (histiocytic) lymphomas. About 40,000 people in the u.s. are diagnosed with lymphomas every yeaõ f which 20,000 have these two varieties. Dr. Devita reviewed important factors influencing patient survival in these studies.
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Please send additional information for _ By reviewing the data on curability of these cancers over a long time period, we can look at what needs to be done, and what should be avoided during treatment, he said. Data were derived from approximately 2,000 patients who participated in clinical trials conducted by NO, some of the cooperative groups of researchers, Stanford University, and the National Cancer Institute of Milan.
Key findings from this review include: • For Hodgkin's disease patients, reduction in doses of chemotherapy in the range of 20%-25% led to significant reductions in long-term survival of approximately 20%-30%.
In the treatment of Hodgkin's disease with the so-called MOPP regimen, pioneered by Dr. DeVita in the 1960s, 55% of patients in the NO study -who received 85% of full dose -had long-term survival (free of disease 10-20 years). Results were different in two other studies: In one cooperativegroup study which administered 60% of the intended dose, (Dose intensity is the optimal or target dose of drug established by researchers who developed the treatment.) patients had 37% longterm survival -a decrease of 29% in dose intensity led to a 33% reduction in long-term survival. In Italian studies where patients received between 53%-66% of full dose, 36% of patients had long-term survival (a 38% decrease in dose intensity led to a 35% decrease in cure rate).
• For large-cell lymphoma patients, the outlook was similar, Dr. DeVita said. As in Hodgkin's disease, the patient outlook is much influenced by dose intensity and the number and rate of exposure to drugs, all of which can be compromised in routine delivery of therapy. He said that data on large-cell lymphomas show that if intense therapy is given during a short period of time, results are better. Reviewing data on lymphomas, Dr. DeVita said, "It was very difficult to calculate the dose intensities because most published reports do not provide sufficient information. I feel strongly that this should be a requirement for future publications. " "The problem," he said, "is that wellmeaning researchers and other physicians have tended to reduce chemotherapy doses because of the unpleasant side effects for patients." Actually, Dr. DeVita said, the greatest toxicity for patients is dose reduction itself, which reduces survival.
Patients can also playa role in their treatment by getting the right information on treatments and by making sure they receive adequatedoses of chemotherapy which may increase their chance of long-term survival. An important resource for cancer patients as well as physicians, is the computerized information system, PDQ, which provides up-todate information on state-of-the-art cancer treatment and clinical trials around the country PDQ not only offers data on which treatment is best for a particular cancer, but describes the protocols themselves, including how much chemotherapy is appropriate.
Dr.-DeVita pointed out that a treatment called CHOP is still the most widely used in the U.S. for diffuse aggressive lymphomas, although less than 30% of patients receiving it experience longterm survival. Between 60% to 75% of patients receiving a numberof more effective treatments for this cancer (all listed in PDQ) show long-term survival. "The best treatments may be more complicated and difficult to deliver, even more toxic," he admits, "but the end result may be that the patient has twice the chance of being cured."
Dr. DeVita added that today we are faced with an "embarrassment of riches" in terms of opportunities to improve chemotherapy and to integrate biologicals with chemotherapy (Biologicals are substances produced by the body's own cells,) It is a wonderful challenge to have so many promising directions, but it will require large numbers of patients to enter studies to get the answers on which treatments are best. "If all patients in this country with lymphomas would enterclinical trials," he said, "this would speed up progress in curing lymphomas immeasurably" NOTE: The National Cancer Institute has developed PDQ (Physician's Data Query), a computerized database designed to give doctors quick and easy access to: the latest treatment information for most types of cancer;descriptionsof clinical trials; and names of organizations and physicians involved in cancercare. Toget access to PDQ, a doctor mayuseanoffice computerwith a telephone hookup and a PDQ access code or the servicesof a medical librarywith onlinesearching capability. Most Cancer Information Service offices (1-800-4-CANCER) provide a physician with one freePDQ search, and can tell doctors how to get regular access to the database. Patients mayask theirdoctor to use PDQ or may call 1-800-4-CANCER themselves.
